Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure
This study is currently recruiting participants.
Study NCT00004496   Information provided by FDA Office of Orphan Products Development
First Received: October 18, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Renal Failure
Additional conditions recognized in this trial
Kidney Failure
Kidney Failure, Acute
More general conditions related to this trial
Kidney Diseases
Renal Insufficiency
Renal Insufficiency, Acute
Urologic Diseases
Additional drug interventions recognized in this trial
Alpha-MSH
Hormones
Melanocyte-Stimulating Hormones
More general drug interventions related to this trial
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
FDA Office of Orphan Products Development
University of Texas


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services